What is the difference between ALBUTEROL SULFATE and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

ALBUTEROL SULFATE and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE are both Beta-2 Agonist Bronchodilators, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Albuterol Sulfate HFA the same as Anoro Ellipta?

No. Albuterol Sulfate HFA (ALBUTEROL SULFATE) and Anoro Ellipta (UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ALBUTEROL SULFATE or UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ALBUTEROL SULFATE to UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Compare ALBUTEROL SULFATE (Albuterol Sulfate HFA) and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE (Anoro Ellipta) — clinical data, side effects, and patient experiences.

ALBUTEROL SULFATE

Albuterol Sulfate HFA · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action In vitro studies and in vivo pharmacologic studies have demonstrated that albuterol has a preferential effect on beta 2 -adrenergic receptors compared with...

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Anoro Ellipta · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action ANORO ELLIPTA ANORO ELLIPTA contains both umeclidinium and vilanterol. The mechanisms of action described below for the individual components apply to ANOR...

Approved for

an anticholinergic

and vilanterol

a long-acting beta 2 -adrenergic agonist (LABA)

5.2 )

Respiratory (inhalation)Tablet

Quick Comparison

ALBUTEROL SULFATEUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALBUTEROL SULFATE

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Shortness of Breath

>10%

Drug Not Working

>10%

Cough

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

ALBUTEROL SULFATE

5 WARNINGS AND PRECAUTIONS Life-threatening paradoxical bronchospasm may occur
7 ) Excessive use may be fatal
5 Do Not Exceed Recommended Dose Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma
The exact cause of death is unknown, but cardiac arrest following an unexpected development of a severe acute asthmatic crisis and subsequent hypoxia is suspected

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

5 WARNINGS AND PRECAUTIONS • LABA monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
2 ) • Do not use in combination with additional therapy containing a LABA because of risk of overdose
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and effectiveness of ANORO ELLIPTA in patients with asthma have not been established
Use of LABA as monotherapy (without ICS) for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE.

ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: What You Should Know

Key Differences

Both ALBUTEROL SULFATE and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE belong to the Beta-2 Agonist Bronchodilator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ALBUTEROL SULFATE carries 4 FDA warnings. UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ALBUTEROL SULFATE vs FORMOTEROL FUMARATE→ALBUTEROL vs ALBUTEROL SULFATE→ALBUTEROL SULFATE vs LEVALBUTEROL HYDROCHLORIDE→ALBUTEROL SULFATE vs FORMOTEROL FUMARATE DIHYDRATE→ALBUTEROL SULFATE vs TIOTROPIUM BROMIDE AND OLODATEROL→ALBUTEROL SULFATE vs FLUTICASONE PROPIONATE AND SALMETEROL→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALBUTEROL SULFATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Compare ALBUTEROL SULFATE (Albuterol Sulfate HFA) and UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE (Anoro Ellipta) — clinical data, side effects, and patient experiences.

ALBUTEROL SULFATE

Albuterol Sulfate HFA · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action In vitro studies and in vivo pharmacologic studies have demonstrated that albuterol has a preferential effect on beta 2 -adrenergic receptors compared with...

Approved for

See full prescribing information

Respiratory (inhalation)Tablet

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Anoro Ellipta · Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action ANORO ELLIPTA ANORO ELLIPTA contains both umeclidinium and vilanterol. The mechanisms of action described below for the individual components apply to ANOR...

Approved for

an anticholinergic

and vilanterol

a long-acting beta 2 -adrenergic agonist (LABA)

5.2 )

Respiratory (inhalation)Tablet

Quick Comparison

ALBUTEROL SULFATEUMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALBUTEROL SULFATE

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

1-10%

Headache

1-10%

Nausea

1-10%

Diarrhea

0.1-1%

General Unwellness

0.1-1%

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

Shortness of Breath

>10%

Drug Not Working

>10%

Cough

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

ALBUTEROL SULFATE

5 WARNINGS AND PRECAUTIONS Life-threatening paradoxical bronchospasm may occur
7 ) Excessive use may be fatal
5 Do Not Exceed Recommended Dose Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma
The exact cause of death is unknown, but cardiac arrest following an unexpected development of a severe acute asthmatic crisis and subsequent hypoxia is suspected

UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE

5 WARNINGS AND PRECAUTIONS • LABA monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
2 ) • Do not use in combination with additional therapy containing a LABA because of risk of overdose
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and effectiveness of ANORO ELLIPTA in patients with asthma have not been established
Use of LABA as monotherapy (without ICS) for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE.

ALBUTEROL SULFATE vs UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALBUTEROL SULFATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE: DailyMed label · FAERS adverse events · ClinicalTrials.gov